P. C. Fuchs

Publication List Details

Period

1982 - 1996

Number

146

Co-Authors

In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits (1996)

Barry, A. L., Fuchs, P. C., Allen, S. D., Brown, S. D., Jorgensen, J. H., Tenover, F. C.

The l-isomer of ofloxacin (levofloxacin) was twice as active as ofloxacin and the d-isomer was inactive against 654 Streptococcus pneumoniae isolates. For disc susceptibility tests of pneumococci, 5...

Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for broth microdilution and disc diffusion methods (1995)

Fuchs, P. C., Barry, A. L., Tenover, F. C., Allen, S. D., Jorgensen, J. H., Murray, P. R.

Proposed quality control (QC) parameters for susceptibility testing of Streptococcus pneumoniae to cefdinir were developed following the procedure recommended by the National Committee for Clinical...

In-vitro activity of five {beta}-lactam/{beta}-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa (1994)

McLaughlin, J. C., Barry, A. L., Fuchs, P. C., Gerlach, E. H., Hardy, D. J., Pfaller, M. A.

Susceptibility tests were performed on 2402 of consecutive isolates of Enterobacteriaceae and 254 strains of Pseudomonas aeruginosa in five separate medical centres. Five β-lactams were evaluated...

Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin (1993)

Barry, A. L., Fuchs, P. C., Citron, D. M., Allen, S. D., Wexler, H. M.

The susceptibility of anaerobic bacteria to two new fluoroquinolones, PD 131628 (the bioactive form of PD 131112 or CI-990) and clinafloxacin (CI-960 or PD 127391), was determined with the agar...

Cefpiramide: comparative in-vitro activity and {beta}-lactamase stability (1985)

Barry, A. L., Jones, R. N., Thornsberry, C., Fuchs, P. C., Ayers, L. W., Gavan, T. L., ...

Cefpiramide is a new Pseudomonas-active cephalosporin with a broad spectrum of antibacterial activity. Like cefoperazone, cefpiramide was moderately susceptible to hydrolysis by a variety of...

Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, {beta}-lactamase stability, and inhibition (1982)

Barry, A. L., Jones, R. N., Thornsberry, C., Fuchs, P. C., Gerlach, E. H., Sommers, H. M.

Ceftizoxime is a 7-aminothiazolyl α-methoxyimino cephalosporin, a new ‘third-generation’ cephalosporin. A collaborative study was undertaken to document its in vitro activity, β-lactamase...

Antipneumococcal Activities of a Ketolide (HMR 3647), a Streptogramin (Quinupristin-Dalfopristin), a Macrolide (Erythromycin), and a Lincosamide (Clindamycin)

Barry, A. L., Fuchs, P. C., Brown, S. D.

Four different compounds belonging to the macrolide-lincosamide-streptogramin B (MLSb) class of antimicrobial agents were tested against 611 Streptococcus pneumoniae strains. The ketolide (HMR 3647,...

Precision and Accuracy of Fluconazole Susceptibility Testing by Broth Microdilution, Etest, and Disk Diffusion Methods

Barry, A. L., Pfaller, M. A., Rennie, R. P., Fuchs, P. C., Brown, S. D.

Interpretive agreements among the results of fluconazole broth microdilution tests, Etests, and disk diffusion tests were documented by evaluating 495 Candida spp. Microdilution reference test...

In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens.

Barry, A L, Fuchs, P C

Broth microdilution tests were carried out with 2,671 respiratory tract isolates from 19 medical centers throughout the continental United States. The tests compared a streptogramin (RP59500) to...

Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing.

Fuchs, P C, Barry, A L, Sewell, D L

The in vitro antimicrobial activity of an oral penem, WY-49605, was compared with those of six other oral antimicrobial agents against 598 bacterial isolates representing 51 different species....

Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group.

Fuchs, P C, Barry, A L, Brown, S D

More than 3,000 consecutive clinical bacterial isolates from 10 U.S. medical centers were subjected to standard broth microdilution and disk diffusion tests to determine their susceptibilities to...

In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.

Barry, A L, Fuchs, P C, Brown, S D

Ciprofloxacin, clinafloxacin, PD 131628, sparfloxacin, and trovafloxacin were tested against 236 strains of Streptococcus pneumoniae, most of which were resistant to other agents. Resistance to...

In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.

Fuchs, P C, Jones, R N, Barry, A L

E1040 is a new parenteral cephalosporin which was tested against 690 clinical isolates and compared with cefpirome and ceftazidime. E1040 had the best activity of the three drugs against Pseudomonas...

In vitro antimicrobial activity of tigemonam, a new orally administered monobactam.

Fuchs, P C, Jones, R N, Barry, A L

At five geographically separate medical centers, over 6,000 clinical bacterial isolates were tested for their susceptibility to tigemonam by the broth microdilution method. The antimicrobial spectrum...

Multicenter in vitro evaluation of SM-7338, a new carbapenem.

Jones, R N, Aldridge, K E, Allen, S D, Barry, A L, Fuchs, P C, Gerlach, E H, ...

A new carbapenem, SM-7338, was compared with imipenem, cefotaxime, and ceftazidime at five medical centers. Nearly 6,000 strains were tested by reference methods of the National Committee for...

Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.

Fuchs, P C, Jones, R N, Barry, A L, Thornsberry, C

The in vitro activity of BMY-28142, a new cephalosporin, was tested by a broth microdilution system and compared with those of cefotaxime, ceftazidime, cefoperazone, moxalactam, and HR 810 against...

LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks.

Jones, R N, Baker, C, Barry, A L, Fuchs, P C

A new oral cephalosporin, LY164846 (Eli Lilly & Co., Indianapolis, Ind.), was found to have a unique antimicrobial spectrum confined to methicillin-susceptible Staphylococcus spp., streptococci...

Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.

Jones, R N, Fuchs, P C, Barry, A L, Ayers, L W, Gerlach, E H, Gavan, T L

Susceptibility testing of 7,775 recent clinical isolates from four medical centers showed Ro 15-8074 to be 2-to greater than 8-fold more active than either cefaclor or cefuroxime against the...

Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing.

Fuchs, P C, Barry, A L, Thornsberry, C, Jones, R N, Gerlack, E H

The susceptibility of 447 clinical bacterial isolates to mezlocillin and carbenicillin was tested by standardized agar disk diffusion and reference broth micro-dilution methods. Tentative...

In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

Fuchs, P C, Barry, A L, Thornsberry, C, Gavan, T L, Jones, R N

Augmentin (Beecham Laboratories, Bristol, Tenn.), a combination drug consisting of two parts amoxicillin to one part clavulanic acid and a potent beta-lactamase inhibitor, was evaluated in vitro in...

In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.

Fuchs, P C, Barry, A L, Thornsberry, C, Jones, R N

A total of 632 clinical bacterial isolates were tested for susceptibility to twofold dilutions of ticarcillin alone and in combination with 1, 2, and 4 micrograms of clavulanic acid (CA) (Timentin)...

Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.

Ayers, L W, Jones, R N, Barry, A L, Thornsberry, C, Fuchs, P C, Gavan, T L, ...

Cefotetan is a new, potent, 7 alpha-methoxy cephalosporin (cephamycin). The in vitro activity of cefotetan tested in a multiphasic, collaborative study against 12,260 consecutive clinical isolates...

Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.

Barry, A L, Fuchs, P C, Pfaller, M A

In in vitro studies we evaluated the susceptibilities of beta-lactamase-producing and -nonproducing, ampicillin-resistant strains of Haemophilus influenzae and compared them with those of...

Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399.

Pfaller, M A, Barry, A L, Fuchs, P C

Ro 40-6890, the active metabolite of Ro 41-3399, was tested against 391 gram-negative and gram-positive clinical isolates. Ro 40-6890 was active against members of the family Enterobacteriaceae,...

Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae.

Barry, A L, Fuchs, P C, Gerlach, E H, Hardy, D J, McLaughlin, J C, Pfaller, M A

A five-laboratory coordinated study was undertaken to determine whether ticarcillin and ticarcillin-clavulanic acid disk susceptibility tests could accurately detect resistance among enteric bacilli....

Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.

Barry, A L, Fuchs, P C, Allen, S D, Tenover, F C, Jorgensen, J H, Reller, L B

For testing bacterial susceptibility to PD131628, a 5-micrograms disk and the following tentative interpretive criteria may be used: > or = 19 mm for susceptible (MIC, < or = 1.0 micrograms/ml), 16...

Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.

Barry, A L, Fuchs, P C

Among 698 Streptococcus pneumoniae isolates, 475 were penicillin susceptible and > 99% of those were susceptible to 0.5 microgram of cefixime per ml; other pneumococci were tentatively assumed to be...

Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.

Barry, A L, Fuchs, P C

Cefotaxime- and ceftriaxone-resistant Streptococcus pneumoniae is now appearing in some medical centers, but 30-micrograms cefotaxime or 30-micrograms ceftriaxone disks are not reliable for detecting...

Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

Fuchs, P C, Barry, A L, Brown, S D

Two hundred twenty-eight strains of Haemophilus influenzae and 234 strains of Streptococcus pneumoniae were tested by broth microdilution and disk diffusion methods for susceptibility to trimethoprim...

In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.

Fuchs, P C, Stickel, S, Anderson, P H, Barry, A L, Shilling, S

At clinically achievable levels (e.g., 25 micrograms/ml), sulbactam exerted no effect on aminoglycoside concentrations when incubated together in pooled serum at 37 degrees C for up to 24 h....

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates.

Fuchs, P C, Barry, A L, Pfaller, M A, Allen, S D, Gerlach, E H

The in vitro activities of three new quinolones (sparfloxacin, CI-960, and PD 131,628) were compared with that of ciprofloxacin against 5,252 routine clinical aerobic and facultatively anaerobic...

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.

Barry, A L, Fuchs, P C

The in vitro activity of sparfloxacin was compared with those of tosufloxacin, ciprofloxacin, and fleroxacin against 730 bacterial isolates representing 49 different species. Sparfloxacin and...

Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests.

Barry, A L, Fuchs, P C, Jorgensen, J H, Tenover, F C, Allen, S D, Hardy, D J, ...

In vitro studies evaluated methods for testing the susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations. Ampicillin-resistant beta-lactamase-nonproducing strains of H....

Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.

Fuchs, P C, Barry, A L

One hundred fifty isolates of Haemophilus influenzae (including 30 beta-lactamase-positive strains and 23 beta-lactamase-negative, ampicillin-resistant strains) were tested for susceptibilities to...

Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin.

Barry, A L, Cohen, M A, Sesnie, J C, Fuchs, P C, Washington, J A, Murray, P R, ...

For testing the susceptibility of Neisseria gonorrhoeae to enoxacin, a proposed susceptibility category includes strains for which MICs are less than or equal to 0.5 micrograms/ml and zones of...

Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae.

Fuchs, P C, Barry, A L, Baker, C, Murray, P R, Washington, J A

A multilaboratory study designed to determine the in vitro susceptibility criteria and quality control parameters for ofloxacin against Neisseria gonorrhoeae was conducted according to the guidelines...

Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations.

Fuchs, P C, Barry, A L, Baker, C N, Murray, P R, Washington, J A

To support future clinical studies, in vitro susceptibility tests were examined to determine whether Neisseria gonorrhoeae could be tested reliably against two beta-lactam-clavulanate combinations....

Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests.

Pfaller, M A, Barry, A L, Fuchs, P C

Levofloxacin disk susceptibility test criteria were evaluated by testing 350 bacterial isolates. Either 5- or 10-micrograms disks could be used satisfactorily. A 5-micrograms levofloxacin disk with...

Ramoplanin susceptibility testing criteria.

Barry, A L, Pfaller, M A, Fuchs, P C

Ramoplanin and mupirocin are two antimicrobial agents that may be applied topically. They had similar potencies against susceptible gram-positive cocci, but they differed in their spectra of...

Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.

Fuchs, P C, Barry, A L, Pfaller, M A

Susceptibility to sparfloxacin was tested simultaneously by the agar dilution and disk diffusion methods. For tests with 5-micrograms sparfloxacin disks, we propose that the breakpoints for the...

Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.

Barry, A L, Fuchs, P C, Allen, S D, Jorgensen, J H, Tenover, F C, Murray, P R, ...

Sparfloxacin and levofloxacin were evaluated against 150 Haemophilus influenzae isolates and 149 Neisseria gonorrhoeae isolates in order to define susceptibility testing parameters....

Quality control limits for microdilution susceptibility tests with norfloxacin.

Barry, A L, Gavan, T L, Ayers, L W, Fuchs, P C, Gerlach, E H, Thornsberry, C

A multilaboratory study was designed to define quality control limits for microdilution susceptibility tests with norfloxacin. The following limits were proposed: for Escherichia coli ATCC 25922,...

Antimicrobic susceptibility and plasmid profile analysis as identity tests for multiple blood isolates of coagulase-negative staphylococci.

Hartstein, A I, Valvano, M A, Morthland, V H, Fuchs, P C, Potter, S A, Crosa, J H

We compared a disk diffusion antimicrobic susceptibility panel with plasmid DNA profiles as tests for identity of 106 isolates of coagulase-negative staphylococci cultured from the blood of 45...

Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.

Fuchs, P C, Barry, A L, Jones, R N

A total of 97 anaerobic bacteria were tested for susceptibility to ampicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid by broth microdilution and disk elution methods, the results of...

Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.

Fuchs, P C, Jones, R N, Barry, A L

There are at least four different existing or proposed interpretive criteria for the disk diffusion susceptibility testing of ticarcillin and ticarcillin plus clavulanic acid (T/C). To assess these...

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

Jones, R N, Gavan, T L, Thornsberry, C, Fuchs, P C, Gerlach, E H, Knapp, J S, ...

A six-laboratory study developed a standardized method for determining the susceptibilities of Neisseria gonorrhoeae strains to penicillin, tetracycline, spectinomycin, and ceftriaxone. Three quality...

Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.

Fuchs, P C, Jones, R N, Barry, A L, Gavan, T L

The susceptibilities of 221 clinical isolates to ofloxacin were tested simultaneously by broth microdilution and disk diffusion methods with commercially prepared 5-micrograms ofloxacin disks. The...

Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.

Zabransky, R J, Bobey, D G, Barry, A L, Allen, S D, Fuchs, P C, Gerlach, E H, ...

Reference values for quality control of in vitro susceptibility tests with cefotetan against anaerobic bacteria were determined in two independent multilaboratory studies with the approved National...

Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards.

Barry, A L, Fuchs, P C, Allen, S D, Thornsberry, C, Gerlach, E H, Jones, R N

Multilaboratory studies were performed to develop MIC quality control limits for the National Committee for Clinical Laboratory Standards reference agar dilution method for anaerobic susceptibility...

Proposed disk diffusion susceptibility criteria for ofloxacin.

Fuchs, P C, Barry, A L, Jones, R N, Thornsberry, C

Disk diffusion zone diameter breakpoint criteria for ofloxacin were tentatively established by correlating MICs with 1-, 3-, and 5-micrograms disk inhibitory zone diameters for 638 bacterial isolates...

Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.

Fuchs, P C, Jones, R N, Barry, A L, Thornsberry, C

A total of 750 bacterial isolates, including 37 different species, were tested for susceptibility to BMY-28142 by standardized broth microdilution and disk diffusion tests. The zone diameter...

Selection of a reference lot of Mueller-Hinton agar.

Pollock, H M, Barry, A L, Gavan, T L, Fuchs, P C, Hansen, S, Thornsberry, C L, ...

A collaborative study was undertaken to evaluate the performance of currently marketed Mueller-Hinton agars from seven manufacturers by replicate disk diffusion tests with standard quality control...

Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

Jones, R N, Barry, A L, Fuchs, P C, Thornsberry, C

The 15-micrograms erythromycin disk was twice evaluated for interpretive accuracy against 417 and then 266 strains of gram-positive cocci, Neisseria meningitidis, and Haemophilus influenzae by using...

Tentative disk diffusion susceptibility interpretive criteria for pefloxacin.

Fuchs, P C, Barry, A L, Jones, R N, Thornsberry, C

Standardized broth microdilution and disk diffusion susceptibility tests for pefloxacin were performed on 585 clinical isolates. The 5-micrograms pefloxacin disk is recommended, and the following...

Cefixime disk susceptibility test criteria.

Fuchs, P C, Barry, A L, Jones, R N

A total of 583 bacterial isolates was tested for susceptibility to cefixime by broth microdilution and by disk agar diffusion with 5-, 10-, and 30-microgram disks. At MIC breakpoints of less than or...

Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.

Jones, R N, Barry, A L, Fuchs, P C, Thornsberry, C

Cefmetazole, formerly CS-1170, was found to have antimicrobial activity slightly superior to that of cefoxitin but a clinically usable antimicrobial spectrum that should be considered identical to...

Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Fuchs, P C, Jones, R N, Barry, A L

Five hundred gram-positive clinical bacterial isolates were tested for susceptibility to mupirocin by broth microdilution and disk diffusion methods (5- and 10-micrograms disks). All but 1 of 330...

Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Fuchs, P C, Barry, A L, Baker, C, Murray, P R, Washington, J A

Ciprofloxacin was subjected to a multilaboratory study designed to determine its in vitro susceptibility criteria for Neisseria gonorrhoeae and its quality control parameters for both agar dilution...

Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.

Barry, A L, Jorgensen, J H, Hardy, D J, Allen, S D, Baker, C N, Fuchs, P C, ...

Haemophilus influenzae isolates were uniformly susceptible to enoxacin, ofloxacin, and temafloxacin. Zone diameter and MIC interpretive criteria were proposed to define susceptible populations so...

Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.

Fuchs, P C, Jones, R N, Barry, A L, Thornsberry, C

Disk diffusion susceptibility testing of ticarcillin plus the beta-lactamase inhibitor clavulanic acid was performed on 489 clinical isolates, and the results were compared with reference broth...

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.

Jones, R N, Thornsberry, C, Barry, A L, Ayers, L, Brown, S, Daniel, J, ...

HR810 is a new, very broad-spectrum cephalosporin with significant activity against members of the family Enterobacteriaceae, pseudomonads, gram-positive cocci, and anaerobes that is generally...

Cefotiam susceptibility testing criteria.

Fuchs, P C, Barry, A L, Jones, R N, Thornsberry, C

Interpretive zone size breakpoints for diffusion tests with 30-micrograms cefotiam disks are diameters of greater than or equal to 18 mm for susceptible and less than or equal to 14 mm for resistant...

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

Gavan, T L, Jones, R N, Barry, A L, Fuchs, P C, Gerlach, E H, Matsen, J M, ...

A multilaboratory in vitro study was carried out to determine disk diffusion susceptibility testing quality control limits for two new semisynthetic penicillins, mezlocillin and piperacillin....

Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.

Jones, R N, Fuchs, P C, Barry, A L, Gavan, T L, Sommers, H M, Gerlach, E H

The in vitro activity of cefoperazone (T-1551) against almost 9,000 recent clinical isolates at six institutions was tested and compared with that of cephalothin and gentamicin. The modal minimum...

Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Jones, R N, Fuchs, P C, Sommers, H M, Gavan, T L, Barry, A L, Gerlach, E H

Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of Enterobacteriaceae, Aeromonas hydrophila, and Pseudomonas maltophilia. The...

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.

Fuchs, P C, Barry, A L, Thornsberry, C, Jones, R N, Gavan, T L, Gerlach, E H, ...

Tested against 9,412 recent clinical isolates, cefotaxime exhibited 8 to 64 times greater activity against the Enterobacteriaceae than did cephalothin and two to four times greater activity against...

In vitro susceptibility testing procedures for fosfomycin tromethamine.

Barry, A L, Fuchs, P C

Fosfomycin tromethamine (previously fosfomycin trometamol) is an orally administered fosfomycin which may be used for single-dose therapy of uncomplicated urinary tract infections. Fosfomycin...

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

Barry, A L, Pfaller, M A, Fuchs, P C, Packer, R R

Clinical isolates of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, and Moraxella catarrhalis were gathered from 19 different clinical laboratories throughout the...

Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.

Jones, R N, Barry, A L, Fuchs, P C, Gavan, T L, Sommers, H M, Gerlach, E H

The susceptibility of 11,840 clinical bacterial isolates to fortimicin A was determined by agar dilution or broth microdilution methods and compared with their susceptibility to amikacin and...

In Vitro Antimicrobial Activity of Cinoxacin Against 2,968 Clinical Bacterial Isolates

Jones, R. N., Fuchs, P. C.

Cinoxacin demonstrated effective in vitro antimicrobial activity against the Enterobacteriaceae, but negligible activity against Pseudomonas aeruginosa and gram-positive cocci. The activity of...

Antipneumococcal Activities of a Ketolide (HMR 3647), a Streptogramin (Quinupristin-Dalfopristin), a Macrolide (Erythromycin), and a Lincosamide (Clindamycin)

Barry, A. L., Fuchs, P. C., Brown, S. D.

Four different compounds belonging to the macrolide-lincosamide-streptogramin B (MLSb) class of antimicrobial agents were tested against 611 Streptococcus pneumoniae strains. The ketolide (HMR 3647,...

Precision and Accuracy of Fluconazole Susceptibility Testing by Broth Microdilution, Etest, and Disk Diffusion Methods

Barry, A. L., Pfaller, M. A., Rennie, R. P., Fuchs, P. C., Brown, S. D.

Interpretive agreements among the results of fluconazole broth microdilution tests, Etests, and disk diffusion tests were documented by evaluating 495 Candida spp. Microdilution reference test...

In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens.

Barry, A L, Fuchs, P C

Broth microdilution tests were carried out with 2,671 respiratory tract isolates from 19 medical centers throughout the continental United States. The tests compared a streptogramin (RP59500) to...

Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing.

Fuchs, P C, Barry, A L, Sewell, D L

The in vitro antimicrobial activity of an oral penem, WY-49605, was compared with those of six other oral antimicrobial agents against 598 bacterial isolates representing 51 different species....

Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group.

Fuchs, P C, Barry, A L, Brown, S D

More than 3,000 consecutive clinical bacterial isolates from 10 U.S. medical centers were subjected to standard broth microdilution and disk diffusion tests to determine their susceptibilities to...

In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.

Barry, A L, Fuchs, P C, Brown, S D

Ciprofloxacin, clinafloxacin, PD 131628, sparfloxacin, and trovafloxacin were tested against 236 strains of Streptococcus pneumoniae, most of which were resistant to other agents. Resistance to...

In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.

Fuchs, P C, Jones, R N, Barry, A L

E1040 is a new parenteral cephalosporin which was tested against 690 clinical isolates and compared with cefpirome and ceftazidime. E1040 had the best activity of the three drugs against Pseudomonas...

In vitro antimicrobial activity of tigemonam, a new orally administered monobactam.

Fuchs, P C, Jones, R N, Barry, A L

At five geographically separate medical centers, over 6,000 clinical bacterial isolates were tested for their susceptibility to tigemonam by the broth microdilution method. The antimicrobial spectrum...

Multicenter in vitro evaluation of SM-7338, a new carbapenem.

Jones, R N, Aldridge, K E, Allen, S D, Barry, A L, Fuchs, P C, Gerlach, E H, ...

A new carbapenem, SM-7338, was compared with imipenem, cefotaxime, and ceftazidime at five medical centers. Nearly 6,000 strains were tested by reference methods of the National Committee for...

Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.

Fuchs, P C, Jones, R N, Barry, A L, Thornsberry, C

The in vitro activity of BMY-28142, a new cephalosporin, was tested by a broth microdilution system and compared with those of cefotaxime, ceftazidime, cefoperazone, moxalactam, and HR 810 against...

LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks.

Jones, R N, Baker, C, Barry, A L, Fuchs, P C

A new oral cephalosporin, LY164846 (Eli Lilly & Co., Indianapolis, Ind.), was found to have a unique antimicrobial spectrum confined to methicillin-susceptible Staphylococcus spp., streptococci...

Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.

Jones, R N, Fuchs, P C, Barry, A L, Ayers, L W, Gerlach, E H, Gavan, T L

Susceptibility testing of 7,775 recent clinical isolates from four medical centers showed Ro 15-8074 to be 2-to greater than 8-fold more active than either cefaclor or cefuroxime against the...

Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing.

Fuchs, P C, Barry, A L, Thornsberry, C, Jones, R N, Gerlack, E H

The susceptibility of 447 clinical bacterial isolates to mezlocillin and carbenicillin was tested by standardized agar disk diffusion and reference broth micro-dilution methods. Tentative...

In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

Fuchs, P C, Barry, A L, Thornsberry, C, Gavan, T L, Jones, R N

Augmentin (Beecham Laboratories, Bristol, Tenn.), a combination drug consisting of two parts amoxicillin to one part clavulanic acid and a potent beta-lactamase inhibitor, was evaluated in vitro in...

In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.

Fuchs, P C, Barry, A L, Thornsberry, C, Jones, R N

A total of 632 clinical bacterial isolates were tested for susceptibility to twofold dilutions of ticarcillin alone and in combination with 1, 2, and 4 micrograms of clavulanic acid (CA) (Timentin)...

Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.

Ayers, L W, Jones, R N, Barry, A L, Thornsberry, C, Fuchs, P C, Gavan, T L, ...

Cefotetan is a new, potent, 7 alpha-methoxy cephalosporin (cephamycin). The in vitro activity of cefotetan tested in a multiphasic, collaborative study against 12,260 consecutive clinical isolates...

Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.

Barry, A L, Fuchs, P C, Pfaller, M A

In in vitro studies we evaluated the susceptibilities of beta-lactamase-producing and -nonproducing, ampicillin-resistant strains of Haemophilus influenzae and compared them with those of...

Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399.

Pfaller, M A, Barry, A L, Fuchs, P C

Ro 40-6890, the active metabolite of Ro 41-3399, was tested against 391 gram-negative and gram-positive clinical isolates. Ro 40-6890 was active against members of the family Enterobacteriaceae,...

Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae.

Barry, A L, Fuchs, P C, Gerlach, E H, Hardy, D J, McLaughlin, J C, Pfaller, M A

A five-laboratory coordinated study was undertaken to determine whether ticarcillin and ticarcillin-clavulanic acid disk susceptibility tests could accurately detect resistance among enteric bacilli....

Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.

Barry, A L, Fuchs, P C, Allen, S D, Tenover, F C, Jorgensen, J H, Reller, L B

For testing bacterial susceptibility to PD131628, a 5-micrograms disk and the following tentative interpretive criteria may be used: > or = 19 mm for susceptible (MIC, < or = 1.0 micrograms/ml), 16...

Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.

Barry, A L, Fuchs, P C

Among 698 Streptococcus pneumoniae isolates, 475 were penicillin susceptible and > 99% of those were susceptible to 0.5 microgram of cefixime per ml; other pneumococci were tentatively assumed to be...

Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.

Barry, A L, Fuchs, P C

Cefotaxime- and ceftriaxone-resistant Streptococcus pneumoniae is now appearing in some medical centers, but 30-micrograms cefotaxime or 30-micrograms ceftriaxone disks are not reliable for detecting...

Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

Fuchs, P C, Barry, A L, Brown, S D

Two hundred twenty-eight strains of Haemophilus influenzae and 234 strains of Streptococcus pneumoniae were tested by broth microdilution and disk diffusion methods for susceptibility to trimethoprim...

In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.

Fuchs, P C, Stickel, S, Anderson, P H, Barry, A L, Shilling, S

At clinically achievable levels (e.g., 25 micrograms/ml), sulbactam exerted no effect on aminoglycoside concentrations when incubated together in pooled serum at 37 degrees C for up to 24 h....

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates.

Fuchs, P C, Barry, A L, Pfaller, M A, Allen, S D, Gerlach, E H

The in vitro activities of three new quinolones (sparfloxacin, CI-960, and PD 131,628) were compared with that of ciprofloxacin against 5,252 routine clinical aerobic and facultatively anaerobic...

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.

Barry, A L, Fuchs, P C

The in vitro activity of sparfloxacin was compared with those of tosufloxacin, ciprofloxacin, and fleroxacin against 730 bacterial isolates representing 49 different species. Sparfloxacin and...

Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests.

Barry, A L, Fuchs, P C, Jorgensen, J H, Tenover, F C, Allen, S D, Hardy, D J, ...

In vitro studies evaluated methods for testing the susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations. Ampicillin-resistant beta-lactamase-nonproducing strains of H....

Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.

Fuchs, P C, Barry, A L

One hundred fifty isolates of Haemophilus influenzae (including 30 beta-lactamase-positive strains and 23 beta-lactamase-negative, ampicillin-resistant strains) were tested for susceptibilities to...

Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin.

Barry, A L, Cohen, M A, Sesnie, J C, Fuchs, P C, Washington, J A, Murray, P R, ...

For testing the susceptibility of Neisseria gonorrhoeae to enoxacin, a proposed susceptibility category includes strains for which MICs are less than or equal to 0.5 micrograms/ml and zones of...

Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae.

Fuchs, P C, Barry, A L, Baker, C, Murray, P R, Washington, J A

A multilaboratory study designed to determine the in vitro susceptibility criteria and quality control parameters for ofloxacin against Neisseria gonorrhoeae was conducted according to the guidelines...

Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations.

Fuchs, P C, Barry, A L, Baker, C N, Murray, P R, Washington, J A

To support future clinical studies, in vitro susceptibility tests were examined to determine whether Neisseria gonorrhoeae could be tested reliably against two beta-lactam-clavulanate combinations....

Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests.

Pfaller, M A, Barry, A L, Fuchs, P C

Levofloxacin disk susceptibility test criteria were evaluated by testing 350 bacterial isolates. Either 5- or 10-micrograms disks could be used satisfactorily. A 5-micrograms levofloxacin disk with...

Ramoplanin susceptibility testing criteria.

Barry, A L, Pfaller, M A, Fuchs, P C

Ramoplanin and mupirocin are two antimicrobial agents that may be applied topically. They had similar potencies against susceptible gram-positive cocci, but they differed in their spectra of...

Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.

Fuchs, P C, Barry, A L, Pfaller, M A

Susceptibility to sparfloxacin was tested simultaneously by the agar dilution and disk diffusion methods. For tests with 5-micrograms sparfloxacin disks, we propose that the breakpoints for the...

Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.

Barry, A L, Fuchs, P C, Allen, S D, Jorgensen, J H, Tenover, F C, Murray, P R, ...

Sparfloxacin and levofloxacin were evaluated against 150 Haemophilus influenzae isolates and 149 Neisseria gonorrhoeae isolates in order to define susceptibility testing parameters....

Quality control limits for microdilution susceptibility tests with norfloxacin.

Barry, A L, Gavan, T L, Ayers, L W, Fuchs, P C, Gerlach, E H, Thornsberry, C

A multilaboratory study was designed to define quality control limits for microdilution susceptibility tests with norfloxacin. The following limits were proposed: for Escherichia coli ATCC 25922,...

Antimicrobic susceptibility and plasmid profile analysis as identity tests for multiple blood isolates of coagulase-negative staphylococci.

Hartstein, A I, Valvano, M A, Morthland, V H, Fuchs, P C, Potter, S A, Crosa, J H

We compared a disk diffusion antimicrobic susceptibility panel with plasmid DNA profiles as tests for identity of 106 isolates of coagulase-negative staphylococci cultured from the blood of 45...

Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.

Fuchs, P C, Barry, A L, Jones, R N

A total of 97 anaerobic bacteria were tested for susceptibility to ampicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid by broth microdilution and disk elution methods, the results of...

Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.

Fuchs, P C, Jones, R N, Barry, A L

There are at least four different existing or proposed interpretive criteria for the disk diffusion susceptibility testing of ticarcillin and ticarcillin plus clavulanic acid (T/C). To assess these...

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

Jones, R N, Gavan, T L, Thornsberry, C, Fuchs, P C, Gerlach, E H, Knapp, J S, ...

A six-laboratory study developed a standardized method for determining the susceptibilities of Neisseria gonorrhoeae strains to penicillin, tetracycline, spectinomycin, and ceftriaxone. Three quality...

Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.

Fuchs, P C, Jones, R N, Barry, A L, Gavan, T L

The susceptibilities of 221 clinical isolates to ofloxacin were tested simultaneously by broth microdilution and disk diffusion methods with commercially prepared 5-micrograms ofloxacin disks. The...

Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.

Zabransky, R J, Bobey, D G, Barry, A L, Allen, S D, Fuchs, P C, Gerlach, E H, ...

Reference values for quality control of in vitro susceptibility tests with cefotetan against anaerobic bacteria were determined in two independent multilaboratory studies with the approved National...

Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards.

Barry, A L, Fuchs, P C, Allen, S D, Thornsberry, C, Gerlach, E H, Jones, R N

Multilaboratory studies were performed to develop MIC quality control limits for the National Committee for Clinical Laboratory Standards reference agar dilution method for anaerobic susceptibility...

Proposed disk diffusion susceptibility criteria for ofloxacin.

Fuchs, P C, Barry, A L, Jones, R N, Thornsberry, C

Disk diffusion zone diameter breakpoint criteria for ofloxacin were tentatively established by correlating MICs with 1-, 3-, and 5-micrograms disk inhibitory zone diameters for 638 bacterial isolates...

Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.

Fuchs, P C, Jones, R N, Barry, A L, Thornsberry, C

A total of 750 bacterial isolates, including 37 different species, were tested for susceptibility to BMY-28142 by standardized broth microdilution and disk diffusion tests. The zone diameter...

Selection of a reference lot of Mueller-Hinton agar.

Pollock, H M, Barry, A L, Gavan, T L, Fuchs, P C, Hansen, S, Thornsberry, C L, ...

A collaborative study was undertaken to evaluate the performance of currently marketed Mueller-Hinton agars from seven manufacturers by replicate disk diffusion tests with standard quality control...

Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

Jones, R N, Barry, A L, Fuchs, P C, Thornsberry, C

The 15-micrograms erythromycin disk was twice evaluated for interpretive accuracy against 417 and then 266 strains of gram-positive cocci, Neisseria meningitidis, and Haemophilus influenzae by using...

Tentative disk diffusion susceptibility interpretive criteria for pefloxacin.

Fuchs, P C, Barry, A L, Jones, R N, Thornsberry, C

Standardized broth microdilution and disk diffusion susceptibility tests for pefloxacin were performed on 585 clinical isolates. The 5-micrograms pefloxacin disk is recommended, and the following...

Cefixime disk susceptibility test criteria.

Fuchs, P C, Barry, A L, Jones, R N

A total of 583 bacterial isolates was tested for susceptibility to cefixime by broth microdilution and by disk agar diffusion with 5-, 10-, and 30-microgram disks. At MIC breakpoints of less than or...

Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.

Jones, R N, Barry, A L, Fuchs, P C, Thornsberry, C

Cefmetazole, formerly CS-1170, was found to have antimicrobial activity slightly superior to that of cefoxitin but a clinically usable antimicrobial spectrum that should be considered identical to...

Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Fuchs, P C, Jones, R N, Barry, A L

Five hundred gram-positive clinical bacterial isolates were tested for susceptibility to mupirocin by broth microdilution and disk diffusion methods (5- and 10-micrograms disks). All but 1 of 330...

Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Fuchs, P C, Barry, A L, Baker, C, Murray, P R, Washington, J A

Ciprofloxacin was subjected to a multilaboratory study designed to determine its in vitro susceptibility criteria for Neisseria gonorrhoeae and its quality control parameters for both agar dilution...

Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.

Barry, A L, Jorgensen, J H, Hardy, D J, Allen, S D, Baker, C N, Fuchs, P C, ...

Haemophilus influenzae isolates were uniformly susceptible to enoxacin, ofloxacin, and temafloxacin. Zone diameter and MIC interpretive criteria were proposed to define susceptible populations so...

Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.

Fuchs, P C, Jones, R N, Barry, A L, Thornsberry, C

Disk diffusion susceptibility testing of ticarcillin plus the beta-lactamase inhibitor clavulanic acid was performed on 489 clinical isolates, and the results were compared with reference broth...

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.

Jones, R N, Thornsberry, C, Barry, A L, Ayers, L, Brown, S, Daniel, J, ...

HR810 is a new, very broad-spectrum cephalosporin with significant activity against members of the family Enterobacteriaceae, pseudomonads, gram-positive cocci, and anaerobes that is generally...

Cefotiam susceptibility testing criteria.

Fuchs, P C, Barry, A L, Jones, R N, Thornsberry, C

Interpretive zone size breakpoints for diffusion tests with 30-micrograms cefotiam disks are diameters of greater than or equal to 18 mm for susceptible and less than or equal to 14 mm for resistant...

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

Gavan, T L, Jones, R N, Barry, A L, Fuchs, P C, Gerlach, E H, Matsen, J M, ...

A multilaboratory in vitro study was carried out to determine disk diffusion susceptibility testing quality control limits for two new semisynthetic penicillins, mezlocillin and piperacillin....

Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.

Jones, R N, Fuchs, P C, Barry, A L, Gavan, T L, Sommers, H M, Gerlach, E H

The in vitro activity of cefoperazone (T-1551) against almost 9,000 recent clinical isolates at six institutions was tested and compared with that of cephalothin and gentamicin. The modal minimum...

Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Jones, R N, Fuchs, P C, Sommers, H M, Gavan, T L, Barry, A L, Gerlach, E H

Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of Enterobacteriaceae, Aeromonas hydrophila, and Pseudomonas maltophilia. The...

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.

Fuchs, P C, Barry, A L, Thornsberry, C, Jones, R N, Gavan, T L, Gerlach, E H, ...

Tested against 9,412 recent clinical isolates, cefotaxime exhibited 8 to 64 times greater activity against the Enterobacteriaceae than did cephalothin and two to four times greater activity against...

In vitro susceptibility testing procedures for fosfomycin tromethamine.

Barry, A L, Fuchs, P C

Fosfomycin tromethamine (previously fosfomycin trometamol) is an orally administered fosfomycin which may be used for single-dose therapy of uncomplicated urinary tract infections. Fosfomycin...

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

Barry, A L, Pfaller, M A, Fuchs, P C, Packer, R R

Clinical isolates of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, and Moraxella catarrhalis were gathered from 19 different clinical laboratories throughout the...

Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.

Jones, R N, Barry, A L, Fuchs, P C, Gavan, T L, Sommers, H M, Gerlach, E H

The susceptibility of 11,840 clinical bacterial isolates to fortimicin A was determined by agar dilution or broth microdilution methods and compared with their susceptibility to amikacin and...

In Vitro Antimicrobial Activity of Cinoxacin Against 2,968 Clinical Bacterial Isolates

Jones, R. N., Fuchs, P. C.

Cinoxacin demonstrated effective in vitro antimicrobial activity against the Enterobacteriaceae, but negligible activity against Pseudomonas aeruginosa and gram-positive cocci. The activity of...